Drug Profile
Cipepofol - Sichuan Haisco Pharmaceutical
Alternative Names: Ciprofol; CS-0064163; GTPL10812; HSK-3486; HY-116152Latest Information Update: 20 Nov 2023
Price :
$50
*
At a glance
- Originator Sichuan Haisco Pharmaceutical
- Class Cyclopropanes; General anaesthetics; Phenols; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Anaesthesia; Sedation
Most Recent Events
- 10 Sep 2023 Pharmacokinetics and pharmacodynamics data from a preclinical trial presented at the American College of Clinical Pharmacology Annual Meeting (ACCP-2023)
- 01 Aug 2023 Zhejiang Cancer Hospital initiates a clinical trial for Sedation in the US (IV, Infusion) (NCT06178926)
- 09 May 2023 Xijing Hospital plans a clinical trial for Anesthesia (In adults, In the Elderly) (IV) in May 2023 (NCT05843383)